Pneumococcal vaccination in diabetic patients: review from clinical practice

Abstract The Middle East and North Africa (MENA) region has the second-highest rate of increase in diabetes, especially in KSA, Egypt, and UAE. Diabetes accounts for a significant economic burden in terms of the cost of treatment, the management of complications, disability, and the loss of producti...

Full description

Bibliographic Details
Main Author: Amr Ghit
Format: Article
Language:English
Published: SpringerOpen 2023-02-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
Online Access:https://doi.org/10.1186/s43162-023-00202-7
_version_ 1797863441423138816
author Amr Ghit
author_facet Amr Ghit
author_sort Amr Ghit
collection DOAJ
description Abstract The Middle East and North Africa (MENA) region has the second-highest rate of increase in diabetes, especially in KSA, Egypt, and UAE. Diabetes accounts for a significant economic burden in terms of the cost of treatment, the management of complications, disability, and the loss of productivity. Diabetic adults have an increased susceptibility to infections due to the presence of hyperglycemia. The risk of pneumonia is higher in patients with diabetes. Pneumonia caused by Streptococcus pneumoniae (pneumococcal infections) is the most frequent cause of hospitalization in KSA, which also increases the risk of mortality in diabetic patients. The annual planned pilgrimage to Mecca, KSA, is one of the largest frequent religious gatherings globally, and outbreaks of infectious diseases are of great concern. This review will discuss the pneumococcal infection outbreak and prevention in patients with diabetes in KSA. Also, it will gather information discussed by a scientific advisory board held in Riyadh in 2020 covering the current understanding of pneumococcal disease prevention in diabetic patients and recommendations to overcome barriers facing vaccination.
first_indexed 2024-04-09T22:36:45Z
format Article
id doaj.art-09b1028fe61543ec8e9d56bb20259f21
institution Directory Open Access Journal
issn 2090-9098
language English
last_indexed 2024-04-09T22:36:45Z
publishDate 2023-02-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Internal Medicine
spelling doaj.art-09b1028fe61543ec8e9d56bb20259f212023-03-22T12:26:14ZengSpringerOpenThe Egyptian Journal of Internal Medicine2090-90982023-02-013511510.1186/s43162-023-00202-7Pneumococcal vaccination in diabetic patients: review from clinical practiceAmr Ghit0Department of Medicine and Aging Sciences, “G. d’Annunzio” University of Chieti-PescaraAbstract The Middle East and North Africa (MENA) region has the second-highest rate of increase in diabetes, especially in KSA, Egypt, and UAE. Diabetes accounts for a significant economic burden in terms of the cost of treatment, the management of complications, disability, and the loss of productivity. Diabetic adults have an increased susceptibility to infections due to the presence of hyperglycemia. The risk of pneumonia is higher in patients with diabetes. Pneumonia caused by Streptococcus pneumoniae (pneumococcal infections) is the most frequent cause of hospitalization in KSA, which also increases the risk of mortality in diabetic patients. The annual planned pilgrimage to Mecca, KSA, is one of the largest frequent religious gatherings globally, and outbreaks of infectious diseases are of great concern. This review will discuss the pneumococcal infection outbreak and prevention in patients with diabetes in KSA. Also, it will gather information discussed by a scientific advisory board held in Riyadh in 2020 covering the current understanding of pneumococcal disease prevention in diabetic patients and recommendations to overcome barriers facing vaccination.https://doi.org/10.1186/s43162-023-00202-7DiabetesT2DMS. pneumoniaePneumoniaPneumococcal vaccination
spellingShingle Amr Ghit
Pneumococcal vaccination in diabetic patients: review from clinical practice
The Egyptian Journal of Internal Medicine
Diabetes
T2DM
S. pneumoniae
Pneumonia
Pneumococcal vaccination
title Pneumococcal vaccination in diabetic patients: review from clinical practice
title_full Pneumococcal vaccination in diabetic patients: review from clinical practice
title_fullStr Pneumococcal vaccination in diabetic patients: review from clinical practice
title_full_unstemmed Pneumococcal vaccination in diabetic patients: review from clinical practice
title_short Pneumococcal vaccination in diabetic patients: review from clinical practice
title_sort pneumococcal vaccination in diabetic patients review from clinical practice
topic Diabetes
T2DM
S. pneumoniae
Pneumonia
Pneumococcal vaccination
url https://doi.org/10.1186/s43162-023-00202-7
work_keys_str_mv AT amrghit pneumococcalvaccinationindiabeticpatientsreviewfromclinicalpractice